Recruiting
A Study of LY3471851 in Participants With Eczema
J1P-MC-KFAD - ClinicalTrials.gov - NCT04081350
The main purpose of this study is to learn more about the safety and side effects of LY3471851 when given by injection just under the skin to participants with eczema.
How long will I be in the trial?
The study will last up to 48 weeks and may include up to 23 visits to the study center.
Recruiting
A Study of LY3471851 in Participants With Eczema
J1P-MC-KFAD - ClinicalTrials.gov - NCT04081350
The main purpose of this study is to learn more about the safety and side effects of LY3471851 when given by injection just under the skin to participants with eczema.
How long will I be in the trial?
The study will last up to 48 weeks and may include up to 23 visits to the study center.
Key Requirements
Age :
18-70
Sex:
All
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18-70
Sex
All
Participants must
Participants must have been diagnosed with eczema for at least 12 months
Participants must have active areas of eczema
Participants must be willing and able to have skin biopsies (small samples of skin removed for testing)
Participants must NOT
Participants must not have received certain medications that were applied to the skin for eczema within 14 days prior to baseline (Day 1)
Participants must not have received certain oral or injectable medications or light therapy for eczema within 4 weeks prior to baseline
Participants must not have taken the study drug previously
Trial Summary
Conditions the trial is for
Atopic Dermatitis (Eczema)
What the trial is testing?
LY3471851, Placebo
Could I receive a Placebo?
yes
Enrollment Goal
40
Trial Dates
December 2019 - April 2021
Trial Phase
1
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18-70
Sex
All
Participants must
Participants must have been diagnosed with eczema for at least 12 months
Participants must have active areas of eczema
Participants must be willing and able to have skin biopsies (small samples of skin removed for testing)
Participants must NOT
Participants must not have received certain medications that were applied to the skin for eczema within 14 days prior to baseline (Day 1)
Participants must not have received certain oral or injectable medications or light therapy for eczema within 4 weeks prior to baseline
Participants must not have taken the study drug previously
Trial Summary
Conditions the trial is for
Atopic Dermatitis (Eczema)
What the trial is testing?
LY3471851, Placebo
Could I receive a Placebo?
yes
Enrollment Goal
40
Trial Dates
December 2019 - April 2021
Trial Phase
1
Not the right fit? Sign up to receive updates on new Atopic Dermatitis (Eczema) trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
Atopic Dermatitis (Eczema) Resources
